Acridan-4-carboxylic acids and N-aryl-2-amino-3-toluic acids as planar and antiplanar analogs of antiinflammatory N-arylanthranilic acids.
D000166:Acridines / Q000138:chemical synthesis* / Q000627:therapeutic use; D000596:Amino Acids / Q000138:chemical synthesis* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy / Q000209:etiology; D005528:Foot; D006168:Guinea Pigs; D009682:Magnetic Resonance Spectroscopy; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship; D014050:Toluene / Q000138:chemical synthesis / Q000627:therapeutic use; D014466:Ultraviolet Rays; D062367:ortho-Aminobenzoates / Q000138:chemical synthesis / Q000627:therapeutic use
D000166:Acridines; D000596:Amino Acids; D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D014050:Toluene; D002351:Carrageenan